Mansanades, Juliet J.
HRN: 22-77-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/31/2023
04/06/2023
IV
4.5gms
Q8
Empirical Escalation
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes